HOME > Business Wire > Article
Nidec Announces Preliminary Report on Performance Values (First Quarter of Fiscal Year 2025)
KYOTO, Japan--(
BUSINESS WIRE
)-- As announced today in the "Notice Regarding the Disclosure of the Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2026, Exceeding 45 Days After the Quarter-End," the planned disclosure date for our First Quarter Performance Information for the Fiscal Year Ending March 2026 will be more than 45 days after the end of the quarter. However, we have determined that it is important to provide our investors and other stakeholders with our current preliminary performance information for the first quarter of the fiscal year ending March 2026, and therefore we are notifying you of these preliminary performance information as detailed below.
Please note that the preliminary values do not take into account the impact on the consolidated financial statements of the additional investigation currently ongoing regarding trade transaction issues and tariff issues at our consolidated subsidiaries.
We are currently conducting additional investigations, and depending on the results, we may have to revise our preliminary performance information for the first quarter of the fiscal year ending March 2026 due to the impact of additional expenses, etc. We sincerely apologize to all concerned parties for the inconvenience and concern caused.
Preliminary Performance Information for the Three Months Ended June 30, 2025 (April 1, 2025 to June 30, 2025) | ||||
(Yen in millions) | ||||
| Net sales | Operating profit | Profit before income taxes | Profit attributable to owners of the parent |
For the three months ended | 637,899 | 61,450 | 58,951 | 45,515 |
For the three months ended | 648,166 | 60,062 | 78,406 | 55,987 |
Ratio of change | -1.6% | 2.3% | -24.8% | -18.7% |
(Notes) | ||||
1. The above values do not take into account the impact on the consolidated financial statement of the ongoing additional investigations and may be revised following the results of the additional investigations and the audit by the accounting auditor for the fiscal year ended March 2025. | ||||
2. NIDEC finalized the provisional accounting treatment for the business combination in the year ended March 31, 2025. Consolidated financial statements for the year ended March 31, 2025 reflect the revision of the initially allocated amounts of acquisition cost as NIDEC finalized the provisional accounting treatment for the business combination. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250723842909/en/
Source: Nidec Corporation
Business Wire
-
07/25 15:34 Motorola Solutions Introduces ‘AI Nutrition Labels,’ a First for P...
-
07/25 10:00 Endoscopic AI: AI Medical Service Inc. Has Obtained Regulatory Approva...
-
07/25 06:30 Oasis Continues to Call for the Dismissal of Kusuri No Aoki’s Presid...
-
07/25 04:44 Kyocera Launches Revolutionary TPA Series Thermal Printhead
-
07/25 01:00 Kioxia Commences Sample Shipments of 9th Generation BiCS FLASHTM 512Gb...
-
07/25 00:00 Renesas Announces Loss Resulting from Signing Restructuring Support Ag...
-
07/25 00:00 Renesas Reports Financial Results for the Second Quarter Ended June 30...
-
07/25 00:00 Renesas Announces Establishment of New Subsidiary and Changes as Speci...
-
07/25 00:00 Renesas Announces Consolidated Forecasts
-
07/24 20:05 Coincheck Group N.V. to Announce Financial Results for First Quarter o...
-
07/24 12:00 Mary Kay’s Iconic Pink Cadillac Goes Electric with the All-New OPTIQ
-
07/24 10:00 Konami Gaming, Inc. Awarded Gaming-Related Vendor License in the Unite...
-
07/24 06:46 Nidec Announces Preliminary Report on Performance Values (First Quarte...
-
07/24 06:45 Nidec Announces the Disclosure of the Financial Results for the First ...
-
07/23 16:00 OKI Becomes First Japanese Company to Acquire ISO 56001 International ...
-
07/23 13:00 NTT DATA Named an Emerging Leader in the Emerging Market Quadrant of t...
-
07/23 13:00 Flatiron Health Triples Global Oncology Research Network, Unlocking Mu...
-
07/23 13:00 Huonslab Secures Formulation Patent for Recombinant Human Hyaluronidas...
-
07/22 14:00 GMO Internet Group’s White-Hat Hackers Compete at DEF CON 33 to Show...
-
07/22 13:00 JPXI Adds Corporate Action Information and Expands Listed Issue Inform...
-
07/22 13:00 The TekStart Group Enters into Distribution Agreement with Techno Math...
-
07/22 12:00 NTT Researchers Advance AI and Machine Learning Accuracy, Security and...
-
07/22 11:41 COSMOS Pharmaceutical Selects RELEX Solutions to Optimize Supply Chain...
-
07/22 11:30 Alloy Therapeutics and Kansai Startup Academia Coalition (KSAC) Announ...
-
07/22 11:00 Talitha Koum and Banyan Tree Club & Spa Seoul Launch Sustainable L...
-
07/22 08:00 Faraday Delivers DDR/LPDDR Combo PHY IP Solutions on UMC’s 22ULP and...
-
07/22 06:32 KIOXIA Announces Industry’s First 245.76 TB NVMe SSD Built for the D...
-
07/22 00:00 Access Advance Announces HEVC Advance and VVC Advance Pricing through ...
-
07/21 12:00 Takeda Receives FDA 510(k) Clearance for HyHubTM and HyHubTM Duo Devic...
-
07/18 02:00 AGC Launches Innovative Fluoroelastomer Without the Use of Surfactants...